SMAD3 and endometrial cancer: Similarly, our study showed that 10 μM of ISL reduced TGF-β1-induced expression of N-cadherin, vimentin, and p-Smad3, while increased E-cadherin expression, and finally inhibited the migration of endometrial cancer cells.